The poster will showcase the design and ongoing progress of its Phase 1 study of CID-078 (NCT06577987), a first-in-class, oral macrocycle cyclin A/B RxL inhibitor.

A "Game of Thrones"-style poster that many believed was a simple digital parody became a reality Wednesday as it was placed in front of President Trump during a Cabinet meeting.

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class ...

Circle Pharma announced today that two poster presentations at the American Association for Cancer Research (AACR) Annual Meeting held April 14-19, in Orlando, Florida, highlight promising pre ...

Home Resources Outreach and Education ESA Annual Meeting 2017: NVC Poster Session ESA Annual Meeting 2017: NVC Poster Session The following posters were presented at the ESA Annual Meeting in an ...

Circle Pharma to Present Trials in Progress Poster on CID-078, a First-in-Class Cyclin A/B Inhibitor, at the ASCO 2025 Annual Meeting Provided by Business Wire May 12, 2025, 4:05:00 AM ...